Literature DB >> 14751708

Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis.

Rajesh Gupta1, Alexander Irwin, Mario C Raviglione, Jim Yong Kim.   

Abstract

The UN has launched an initiative to place 3 million people in developing countries on antiretroviral AIDS treatment by end 2005 (the 3 by 5 target). Lessons for HIV/AIDS treatment scale-up emerge from recent experience with multidrug-resistant tuberculosis. Expansion of treatment for multidrug-resistant tuberculosis through the multipartner mechanism known as the Green Light Committee (GLC) has enabled gains in areas relevant to 3 by 5, including policy development, drug procurement, rational use of drugs, and the strengthening of health systems. The successes of the GLC and the obstacles it has encountered provide insights for building sustainable HIV/AIDS treatment programmes.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14751708     DOI： 10.1016/S0140-6736(03)15394-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  6 in total

Review 1.  Barriers to better care for people with AIDS in developing countries.

Authors:  Andrew S Furber; Ian J Hodgson; Alice Desclaux; David S Mukasa
Journal:  BMJ       Date:  2004-11-27

Review 2.  HIV/AIDS epidemiology, pathogenesis, prevention, and treatment.

Authors:  Viviana Simon; David D Ho; Quarraisha Abdool Karim
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

Review 3.  Monitoring HIV treatment in developing countries.

Authors:  Serena P Koenig; Daniel R Kuritzkes; Martin S Hirsch; Fernet Léandre; Joia S Mukherjee; Paul E Farmer; Carlos del Rio
Journal:  BMJ       Date:  2006-03-11

4.  Analysis of Green Light Committee implementation and acquisition of second-line drug resistance.

Authors:  John Z Metcalfe; Eric Vittinghoff; Philip C Hopewell
Journal:  Clin Infect Dis       Date:  2014-12-19       Impact factor: 9.079

5.  Promoting development and uptake of health innovations: The Nose to Tail Tool.

Authors:  Archna Gupta; Cathy Thorpe; Onil Bhattacharyya; Merrick Zwarenstein
Journal:  F1000Res       Date:  2016-03-16

6.  Multidrug-resistant tuberculosis management in resource-limited settings.

Authors:  Eva Nathanson; Catharina Lambregts-van Weezenbeek; Michael L Rich; Rajesh Gupta; Jaime Bayona; Kai Blöndal; José A Caminero; J Peter Cegielski; Manfred Danilovits; Marcos A Espinal; Vahur Hollo; Ernesto Jaramillo; Vaira Leimane; Carole D Mitnick; Joia S Mukherjee; Paul Nunn; Alexander Pasechnikov; Thelma Tupasi; Charles Wells; Mario C Raviglione
Journal:  Emerg Infect Dis       Date:  2006-09       Impact factor: 6.883
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.